Alcohol, poor diets fueling a new category of liver disease: MetALD
The United States is hardly the only country where heavy and binge drinking is a problem. But Americans…
Common foods that mess with focus, even if your diet is healthy
Here’s something to chew on. Brains require nutrients from a variety of foods like fruits, vegetables, fatty fish,…
GLP-1s like Ozempic masked our cancer symptoms
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Possible culprit for ‘spoonful of microplastics’ in our brain
Life in plastic isn’t so fantastic. While there’s debate over how much is actually in our systems, microplastics…
Diabetes drugs used for weight loss face growing concerns
Drugs developed for the treatment of type 2 diabetes or obesity-related conditions have stood out due to their…
Diabetes Detection Needs Better Tools. They’re on the Way
For decades, a diabetes diagnosis has relied largely on measuring blood sugar and seeing whether it crosses a…
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like…
Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke Risk
GLP-1 receptor agonists are showing evidence of sustained cardiovascular effects beyond their established metabolic benefits. Long-term trial data…
This Type of Exercise Could Lower Your Risk of Type 2 Diabetes—and It Takes Less Than 5 Minutes
“Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” New research suggests…
GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice
Animals and housing conditions Experiments were performed in accordance with the Animal Protection Law of the European Union…